Total Payments
$9,366
2024 Payments
$532.01
Companies
48
Transactions
399
Medicare Patients
3,357
Medicare Billing
$379,816
Payment Breakdown by Category
Food & Beverage$8,369 (89.4%)
Travel$900.86 (9.6%)
Education$96.10 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,369 | 396 | 89.4% |
| Travel and Lodging | $900.86 | 2 | 9.6% |
| Education | $96.10 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic MiniMed, Inc. | $1,507 | 15 | $0 (2020) |
| Abbott Laboratories | $868.15 | 48 | $0 (2024) |
| Lilly USA, LLC | $625.44 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $591.62 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $544.60 | 26 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $451.98 | 16 | $0 (2023) |
| Corcept Therapeutics | $450.59 | 25 | $0 (2023) |
| Novo Nordisk Inc | $400.73 | 19 | $0 (2024) |
| MannKind Corporation | $393.44 | 19 | $0 (2023) |
| Dexcom, Inc. | $348.01 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $532.01 | 32 | Abbott Laboratories ($230.86) |
| 2023 | $1,824 | 71 | Abbott Laboratories ($254.55) |
| 2022 | $1,421 | 65 | Abbott Laboratories ($343.59) |
| 2021 | $1,637 | 91 | AstraZeneca Pharmaceuticals LP ($195.83) |
| 2020 | $2,888 | 96 | Medtronic MiniMed, Inc. ($1,406) |
| 2019 | $764.92 | 38 | SANOFI-AVENTIS U.S. LLC ($185.61) |
| 2018 | $217.89 | 5 | BIOTRONIK INC. ($101.85) |
| 2017 | $82.04 | 1 | Medtronic MiniMed, Inc. ($82.04) |
All Payment Transactions
399 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Diabetes Care | ||||||
| 12/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $19.85 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Diabetes Care | ||||||
| 11/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Diabetes Care | ||||||
| 10/15/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Diabetes Care | ||||||
| 08/28/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Endocrinology | ||||||
| 08/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: Diabetes Care | ||||||
| 07/23/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $23.39 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Diabetes Care | ||||||
| 07/16/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Diabetes Care | ||||||
| 06/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Diabetes | ||||||
| 05/24/2024 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Diabetes Care | ||||||
| 05/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardiology | ||||||
| 04/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Diabetes Care | ||||||
| 04/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Diabetes Care | ||||||
| 04/24/2024 | Chiesi USA, Inc. | MYALEPT (Drug) | Food and Beverage | Cash or cash equivalent | $22.03 | General |
| Category: GENERALIZED LIPODYSTROPHY | ||||||
| 04/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: Diabetes Care | ||||||
| 04/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/06/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Automated insulin delivery system | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 800 | 1,607 | $273,081 | $100,308 |
| 2022 | 8 | 620 | 1,301 | $212,946 | $81,440 |
| 2021 | 10 | 1,037 | 1,724 | $271,869 | $111,846 |
| 2020 | 9 | 900 | 1,425 | $246,106 | $86,222 |
Total Patients
3,357
Total Services
6,057
Medicare Billing
$379,816
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 342 | 810 | $182,250 | $69,752 | 38.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 127 | 318 | $30,210 | $7,992 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 59 | $17,228 | $7,887 | 45.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $15,792 | $5,043 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $10,032 | $3,462 | 34.5% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 30 | 30 | $8,100 | $2,805 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 40 | $6,400 | $2,471 | 38.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 149 | 279 | $3,069 | $895.59 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 265 | 667 | $145,835 | $58,105 | 39.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 80 | 192 | $16,060 | $4,865 | 30.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $10,678 | $4,339 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 81 | $12,255 | $4,188 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $10,959 | $3,287 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 25 | $7,246 | $3,092 | 42.7% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 28 | 28 | $7,185 | $2,759 | 38.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 104 | 248 | $2,728 | $803.05 | 29.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 302 | 663 | $135,915 | $57,298 | 42.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 195 | 291 | $42,195 | $18,611 | 44.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 100 | 100 | $30,500 | $11,266 | 36.9% |
| 95250 | Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours | Office | 2021 | 74 | 75 | $18,375 | $8,264 | 45.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 36 | 36 | $13,680 | $5,380 | 39.3% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 108 | 174 | $13,050 | $4,600 | 35.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 33 | 37 | $7,585 | $2,587 | 34.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 19 | 21 | $5,460 | $2,087 | 38.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 153 | 309 | $3,399 | $1,014 | 29.8% |
About Dr. Ryan Singhi, M.D
Dr. Ryan Singhi, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Fort Mill, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1568882009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Singhi, M.D has received a total of $9,366 in payments from pharmaceutical and medical device companies, with $532.01 received in 2024. These payments were reported across 399 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($8,369).
As a Medicare-enrolled provider, Singhi has provided services to 3,357 Medicare beneficiaries, totaling 6,057 services with total Medicare billing of $379,816. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Fort Mill, SC
- Active Since 04/23/2014
- Last Updated 10/21/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568882009
Products in Payments
- Minimed 670G System (Device) $1,335
- FARXIGA (Drug) $544.60
- FREESTYLE LIBRE 3 (Device) $485.41
- JARDIANCE (Drug) $464.43
- Korlym (Drug) $450.59
- AFREZZA (Drug) $393.44
- SOLIQUA 100/33 (Biological) $380.32
- UNITHROID (Drug) $327.73
- Vascepa (Drug) $313.54
- Dexcom G6 Transmitter (Medical Supply) $272.67
- PROCLAIM (Device) $267.12
- TRULICITY (Drug) $248.39
- HUMULIN (Drug) $237.42
- TEPEZZA (Drug) $215.69
- SYNTHROID (Drug) $176.88
- SOLIQUA 100/33 (Drug) $171.47
- MYCAPSSA (Drug) $154.47
- iLet Bionic Pancreas (Device) $149.68
- INSPIRE (Device) $138.63
- CeQur Simplicity (Device) $136.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.